Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
Accumulation of oxalate, resulting in high plasma levels, is a common finding in end-stage renal disease. We investigated plasma concentration and peritoneal clearance of oxalate in 14 patients on continuous ambulatory peritoneal dialysis. The plasma oxalate levels in these patients (30.2 +/- 11.2 mumol/l) were as high as those in hemodialysis patients before dialysis (31.9 +/- 11.1 mumol/l). There was a significant correlation between plasma oxalate and urea nitrogen appearance (UNA). Dietary protein seems to be an important oxalate source in these patients, because the UNA reflects protein intake in stable patients. The mean peritoneal oxalate clearance was 6.64 +/- 1.56 l/day, close to the creatinine clearance. These results suggest that the plasma oxalate levels in CAPD patients may be sufficiently high to induce calcium oxalate deposition, and that methods of increasing oxalate removal and reducing oxalate burden are necessary for CAPD patients.
A
A
Yamauchi
M
M
Fujii
D
D
Shirai
H
H
Mikami
A
A
Okada
E
E
Imai
A
A
Ando
Y
Y
Orita
T
T
Kamada
D000293:Adolescent; D000328:Adult; D000368:Aged; D001806:Blood Urea Nitrogen; D004044:Dietary Proteins / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010070:Oxalates / Q000097:blood* / Q000378:metabolism; D019815:Oxalic Acid; D010531:Peritoneal Dialysis, Continuous Ambulatory; D006435:Renal Dialysis
D004044:Dietary Proteins; D010070:Oxalates; D019815:Oxalic Acid